Back
Avidity Biosciences Stock Price Chart

Meet the founder that's revolutionizing smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
28
RNA
Avidity Biosciences
Last Price:
$29.34
Seasonality Move:
12.26%
7 Day Trial
ALL ACCESS PASS
$
7

Apple's Drop in iPhone Sales Opens the Door for New Entrant
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RNA is experiencing slight selling pressure.
Avidity Biosciences Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 31.88 | Sell |
20-day SMA: | 31.17 | Buy |
50-day SMA: | 31.34 | Buy |
200-day SMA: | 38.82 | Sell |
8-day EMA: | 31.9 | Sell |
20-day EMA: | 31.59 | Buy |
50-day EMA: | 32.09 | Sell |
200-day EMA: | 33.8 | Sell |
Avidity Biosciences Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.2 | Buy |
Relative Strength Index (14 RSI): | 50.31 | Buy |
Chaikin Money Flow: | -438828 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (29.61 - 32.39) | Buy |
Bollinger Bands (100): | (28.77 - 40.73) | Sell |
Avidity Biosciences Technical Analysis
Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Avidity Biosciences Stock
Is Avidity Biosciences Stock a Buy?
-
Avidity Biosciences share price is 31.60 while RNA 8-day simple moving average is 31.88, which is a Sell signal.
-
The stock price of RNA is 31.60 while Avidity Biosciences 20-day SMA is 31.17, which makes it a Buy.
-
Avidity Biosciences 50-day simple moving average is 31.34 while RNA share price is 31.60, making it a Buy technically.
-
RNA stock price is 31.60 and Avidity Biosciences 200-day simple moving average is 38.82, creating a Sell signal.
RNA Technical Analysis vs Fundamental Analysis
Sell
28
Avidity Biosciences (RNA)
is a Sell
Is Avidity Biosciences a Buy or a Sell?
-
Avidity Biosciences stock is rated a SellThe current Avidity Biosciences [RNA] share price is $31.60. The Score for RNA is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
Avidity Biosciences Stock Info
Market Cap:
3.8B
Price in USD:
31.60
Share Volume:
1.1M
Avidity Biosciences 52-Week Range
52-Week High:
56.00
52-Week Low:
21.56
Sell
28
Avidity Biosciences (RNA)
is a Sell
Avidity Biosciences Share Price Forecast
-
What is the Avidity Biosciences stock price today?The Avidity Biosciences stock price is 31.60 USD today.
-
Will RNA stock go up or go down?Avidity Biosciences> share price is forecast to RISE/FALL based on technical indicators
-
Is Avidity Biosciences overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Avidity Biosciences is overvalued.
Is Avidity Biosciences Stock a Buy?
-
Avidity Biosciences share price is 31.60 while RNA 8-day exponential moving average is 31.90, which is a Sell signal.
-
The stock price of RNA is 31.60 while Avidity Biosciences 20-day EMA is 31.59, which makes it a Buy.
-
Avidity Biosciences 50-day exponential moving average is 32.09 while RNA share price is 31.60, making it a Sell technically.
-
RNA stock price is 31.60 and Avidity Biosciences 200-day simple moving average is 33.80, creating a Sell signal.
Fundamental Analysis of Avidity Biosciences
Is Avidity Biosciences a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.01 per share, a decrease this year of $0.96 per share, and a decrease next year of $0.48 per share.
Technical Analysis of Avidity Biosciences
Should I short Avidity Biosciences stock?
-
RNA Moving Average Covergence Divergence (MACD) indicator is 0.2, suggesting Avidity Biosciences is a Buy
-
Avidity Biosciences Relative Strength Index (RSI) is 50.31, which suggest Avidity Biosciences is overbought
-
The Bollinger Bands (25) for Avidity Biosciences is (29.61 - 32.39), which suggest Avidity Biosciences is a Sell
-
The Bollinger Bands (100) for Avidity Biosciences is (28.77 - 40.73), which suggest Avidity Biosciences is a Sell
* Avidity Biosciences stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.